The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.50
Bid: 133.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.256%)
Open: 133.00
High: 135.50
Low: 133.00
Prev. Close: 134.50
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and COVID-19 Update

14 May 2020 07:00

RNS Number : 8340M
Eurocell plc
14 May 2020
 

14 May 2020

 

EUROCELL PLC

(Symbol: ECEL)

 

AGM and COVID-19 Update

 

Eurocell, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, provides the following COVID-19 update ahead of its Annual General Meeting to be held at 3pm today.

 

Initial Actions in Response to COVID-19

As previously announced, performance in the 11 weeks to 20 March 2020 was in line with our expectations and there was no discernible impact on trading from COVID-19. Since then, our manufacturing plants, branch network, distribution and recycling operations have all been closed, in line with the official guidance from the UK Government.

 

Alongside the closure of our operations, we also took a number of significant, swift actions to conserve cash. These included the deferral of non-essential operating costs and the vast majority of planned capital expenditure whilst operations remained closed, and cancellation of the final dividend payment for the year ended 31 December 2019. Also as part of these actions, the Board and other members of the senior management team agreed to a 20% reduction in remuneration. In addition, we have continued to make use of various Government measures available, including the Coronavirus Job Retention Scheme.

 

Bank Facility and Share Placing

We have a strong balance sheet and were able to increase our bank facility to £75 million in March 2020. As previously disclosed, we continue to believe our banks will be supportive of reviewing covenants, if required.

 

Given the ongoing uncertainty of the COVID-19 situation, on 1 April we raised approximately £17.6m by way of a share placing. Net proceeds will be used to ensure we retain headroom on our bank facility, even under an extended shut-down, and to provide sufficient liquidity for investment in our new state-of-the-art warehouse. As well as being key to increasing total capacity, the new warehouse will deliver improved operational efficiencies. Good headroom on our bank facility will ensure the business is well placed to capitalise on opportunities when markets re-open.

 

Re-opening Plans

We are now pleased to announce that, following the latest guidance from the Government, which permits tradesmen to work in domestic dwellings so long as appropriate precautions are taken, we have implemented the first steps towards re-opening the business. On 11 May we recommenced supply to our fabricator customers from existing stocks and opened six branches around the country. This is allowing us to test our safe-working practices and begin to assess the level of customer demand.

 

We are encouraged that trading over the first three days has been robust, although it is not yet clear whether this is a result of pent up or underlying demand. Subject to the on-going results from these activities, and in particular there being sufficient underlying demand, we plan a phased re-opening of the business over the coming weeks. This includes a return to manufacturing when required to ensure continuity of supply to customers.

 

In the meantime, fit-out of the new warehouse remains on track and we continue to target being operational early in 2021, although this date may still be affected by COVID-19 developments.

 

We will provide a further update when there is more clarity on the impact of COVID-19 on the Group.

 

Annual General Meeting

The 2020 Annual General Meeting will be held at 3pm today at Fairbrook House, Clover Nook Road, Alfreton, Derbyshire, DE55 4RF. As previously announced, and in line with Government guidance in relation to COVID-19, shareholders, proxies and other attendees will not be permitted to attend the AGM in person and shareholders have been strongly advised to vote by proxy. A facility to ask the directors questions by email was made available. Answers will be published, in due course, on the Company's website: www.eurocell.co.uk.

 

~~~~~~~~~~~~~~~~~~~~~~~

 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

 

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

Teneo

Ben Foster

+44 (0) 777 624 0806

 

Camilla Cunningham

+44 (0) 7464 982 426

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCVXLFFBELFBBL
Date   Source Headline
22nd Feb 202112:02 pmRNSNotice of Full Year Results Announcement
15th Jan 20217:00 amRNSYear End Trading Update – Strong Finish to 2020
12th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20203:00 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInvestor Presentation
17th Nov 20207:00 amRNSTrading Update – Improved Outlook
2nd Nov 20207:00 amRNSTotal Voting Rights
27th Oct 202011:23 amRNSHolding(s) in Company
15th Oct 202012:30 pmRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNSTotal Voting Rights
16th Sep 202012:20 pmRNSDirector/PDMR Shareholding
11th Sep 20207:00 amRNSDirector/PDMR Shareholding
7th Sep 202010:37 amRNSBlock listing Interim Review
4th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
2nd Sep 20209:59 amRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20209:59 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSTotal Voting Rights
8th Jul 20207:00 amRNSCOVID-19 and Trading Update
1st Jul 20209:34 amRNSTotal Voting Rights
30th Jun 20204:53 pmRNSNotice of Results
4th Jun 202011:47 amRNSDirector Declaration
26th May 20209:37 amRNSBlock Listing Application
19th May 20208:46 amRNSResult of AGM - Correction
15th May 202011:34 amRNSResult of AGM
14th May 20207:00 amRNSAGM and COVID-19 Update
30th Apr 20205:09 pmRNSHolding(s) in Company
17th Apr 202012:55 pmRNSAnnual Financial Report
16th Apr 20205:02 pmRNSHolding(s) in Company
14th Apr 20202:52 pmRNSDirector/PDMR Shareholding
7th Apr 20202:14 pmRNSHolding(s) in Company
3rd Apr 202012:13 pmRNSHolding(s) in Company
1st Apr 20203:22 pmRNSDirector/PDMR Shareholding
1st Apr 20203:21 pmRNSResult of Placing
1st Apr 202011:43 amRNSPlacing of Ordinary Shares
24th Mar 20202:44 pmRNSCOVID-19 Update
13th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
11th Mar 20203:59 pmRNSTransaction in Own Shares
10th Mar 20204:34 pmRNSBlock listing Interim Review
7th Jan 202012:29 pmRNSForm 8.3 - Eurocell PLC
11th Dec 20197:00 amRNSTrading Update
9th Dec 20199:44 amRNSHolding(s) in Company
21st Oct 20191:16 pmRNSHolding(s) in Company
17th Oct 20193:26 pmRNSHolding(s) in Company
17th Oct 20193:11 pmRNSHolding(s) in Company
1st Oct 20197:00 amRNSTotal Voting Rights
20th Sep 20195:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.